Abstract

Mammalian sex determination is controlled by antagonistic gene cascades operating in embryonic undifferentiated gonads. The expression of the Y-linked gene SRY is sufficient to trigger the testicular pathway, whereas its absence in XX embryos leads to ovarian differentiation. Yet, the potential involvement of non-coding regulation in this process remains unclear. Here we show that the deletion of a single microRNA cluster, miR-17~92, induces complete primary male-to-female sex reversal in XY mice. Sry expression is delayed in XY knockout gonads, which develop as ovaries. Sertoli cell differentiation is reduced, delayed and unable to sustain testicular development. Pre-supporting cells in mutant gonads undergo a transient state of sex ambiguity which is subsequently resolved towards the ovarian fate. The miR-17~92 predicted target genes are upregulated, affecting the fine regulation of gene networks controlling gonad development. Thus, microRNAs emerge as key components for mammalian sex determination, controlling Sry expression timing and Sertoli cell differentiation.

The cluster miR-17~92 modulates the expression of genes networks and signalling pathways to ensure proper Sry expression timing and subsequent testis differentiation, an unexpected role for miRNAs in the early steps of mammalian sex determination.

Details

Title
Complete male-to-female sex reversal in XY mice lacking the miR-17~92 cluster
Author
Hurtado, Alicia 1   VIAFID ORCID Logo  ; Mota-Gómez, Irene 2   VIAFID ORCID Logo  ; Lao, Miguel 3   VIAFID ORCID Logo  ; Real, Francisca M. 4   VIAFID ORCID Logo  ; Jedamzick, Johanna 2 ; Burgos, Miguel 3   VIAFID ORCID Logo  ; Lupiáñez, Darío G. 5   VIAFID ORCID Logo  ; Jiménez, Rafael 3   VIAFID ORCID Logo  ; Barrionuevo, Francisco J. 3   VIAFID ORCID Logo 

 Labs. 127 and A105, Centre for Biomedical Research, University of Granada, Armilla, Department of Genetics and Institute of Biotechnology, Granada, Spain (GRID:grid.4489.1) (ISNI:0000 0001 2167 8994); Max-Delbrück Center for Molecular Medicine, Epigenetics and Sex Development Group, Berlin Institute for Medical Systems Biology, Berlin, Germany (GRID:grid.419491.0) (ISNI:0000 0001 1014 0849); CSIC/UPO/JA, Centro Andaluz de Biología del Desarrollo (CABD), Seville, Spain (GRID:grid.428448.6) (ISNI:0000 0004 1806 4977) 
 Max-Delbrück Center for Molecular Medicine, Epigenetics and Sex Development Group, Berlin Institute for Medical Systems Biology, Berlin, Germany (GRID:grid.419491.0) (ISNI:0000 0001 1014 0849) 
 Labs. 127 and A105, Centre for Biomedical Research, University of Granada, Armilla, Department of Genetics and Institute of Biotechnology, Granada, Spain (GRID:grid.4489.1) (ISNI:0000 0001 2167 8994) 
 Max Planck Institute for Molecular Genetics, Research Group Development & Disease, Berlin, Germany (GRID:grid.419538.2) (ISNI:0000 0000 9071 0620) 
 Max-Delbrück Center for Molecular Medicine, Epigenetics and Sex Development Group, Berlin Institute for Medical Systems Biology, Berlin, Germany (GRID:grid.419491.0) (ISNI:0000 0001 1014 0849); CSIC/UPO/JA, Centro Andaluz de Biología del Desarrollo (CABD), Seville, Spain (GRID:grid.428448.6) (ISNI:0000 0004 1806 4977) 
Pages
3809
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3051760212
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.